NAV PER SHARE $16.09 
 SMI 8,298.82 -121.76 
 SPI 8,205.66 53.77 
NAV Data: 4/17/2014
SMI/SPI Data: 4/19/2014
2/13/2014: The Swiss Helvetia Fund, Inc. Announces Final Results Of Tender Offer
2/12/2014: The Swiss Helvetia Fund, Inc. Announces Expiration And Preliminary Results Of Tender Offer
TEN LARGEST HOLDINGS
As of March 31, 2014
Roche Holding Genus (197,950) 13.69%
Novartis AG (606,750) 11.88%
Nestle SA (512,200) 8.90%
Actelion Ltd (247,000) 5.40%
Lindt & Spruengli (344) 4.67%
Burckhardt Compression Holding AG (34,974) 4.20%
ABB Ltd - Reg (598,000) 3.56%
Swiss Life Holding (62,903) 3.56%
Lonza Group AG (150,500) 3.54%
Zurmont Madison Private Equity, L.P. (19,594,212) 3.51%
WELCOME TO THE SWISS HELVETIA FUND INC.
The Fund is a non-diversified, closed-end investment company whose objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. The Fund also may acquire and hold equity and equity-linked securities of non-Swiss companies in limited instances.
The Fund is listed on the New York Stock Exchange under the symbol “SWZ.”
Net Asset Value is calculated daily by 6:15 P.M. (Eastern Time). The most recent calculation is available by calling 1-888-SWISS-00 or by accessing our Website. Net Asset Value is also published weekly in Barron’s, the Monday edition of The Wall Street Journal and the Sunday Edition of The New York Times.
About the Fund
• The Fund
• Board of Directors
• Audit Committee Charter
• Investment Policy
• Investment Advisor
• Insider Filings
• Proxy History
Net Asset Value
• Portfolio
• Performance
• Financial Highlights
• Statement of Operations
• Assets & Liabilities
• Net Assets
Dividends
• Reinvestment Information
• Tax Information
• Dividend History
Publications
• Press Releases
• Swiss News
• Annual and Quarterly Reports
• Proxy Statement
• Voting Results
• Shareholder Presentation
   Privacy Policy Contact Us